Champions Oncology, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
SCHEDULE 13G/A: Tocqueville Asset Management and Affiliates Disclose 4.4% Passive Stake in Champions Oncology
Tocqueville Asset Management L.P., along with Taubenpost Capital L.P., Taubenpost Capital LLC, and Donald Wang, have disclosed a collective passive beneficial ownership of 4.4% in Champions Oncology, Inc. as of December 31, 2024.